Skip to content

Podcasts

Conversations with the people building the data layer.

Two shows from CorrDyn. One explores how life sciences companies turn data into competitive advantage. The other cuts through hype in the broader data ecosystem. 107+ episodes and counting.

107+
Episodes
2
Series
85+
Guest companies
Weekly
New episodes

Our Shows

Each series serves a different audience. Pick the one that matches where you are.

Visual metaphor for Data in Biotech — How life sciences companies turn data into a competitive edge.
Data in Biotech podcast cover art77 episodes

Data in Biotech

How life sciences companies turn data into a competitive edge.

Honest, technical conversations about how biotech, pharma, and life sciences orgs actually use data — from ML pipelines and computational biology to manufacturing analytics and clinical reporting.

For

Directors, VPs, and heads of data inside life sciences companies, plus the practitioners building the platforms underneath them.

  • Implementation specifics from people who have shipped: stack choices, team structure, what broke, what worked.
  • Cross-functional context — how data work survives regulated environments, scientific stakeholders, and limited sample sizes.
  • A working knowledge graph of who is doing what across the industry, episode by episode.

Hosted by Ross Katz · Guest interviews

Apple PodcastsSpotifyYouTube
Visual metaphor for Eventual Consistency — A practitioner's reality check on the modern data ecosystem.
Eventual Consistency podcast cover art30 episodes

Eventual Consistency

A practitioner's reality check on the modern data ecosystem.

Two CorrDyn principals translate the headlines — vendor moves, acquisitions, AI launches, pricing changes — into what they actually mean for the people running data platforms.

For

Data leaders and senior practitioners deciding what to adopt, what to ignore, and what to budget for next quarter.

  • No vendor pitches. Two consultants saying what they actually think about the news this week.
  • Coverage spans data engineering, analytics strategy, vendor landscape, and the business of running a team.
  • Short enough for a commute, opinionated enough to share with your team in Slack.

Hosted by Ross Katz & James Winegar · Co-hosted discussion

Apple PodcastsSpotifyYouTube

Sample an Episode

Press play on a representative episode from each show — no platform required.

Data in Biotech

Foundation models in biomedical AI with Kevin Brown

Eventual Consistency

What MCP Means for Enterprise Data Strategy

Like what you hear?

The same team behind these conversations builds data platforms for companies like yours. Let's talk about what you're working on.

Get your free proposal

Latest Episodes

Recent conversations from both series.

Ross Katz & Jason Bradwell — Why Nvidia's $13B Hugging Face Deal Was Never About Revenue
Eventual ConsistencyEp. 30

Why Nvidia's $13B Hugging Face Deal Was Never About Revenue

with Ross Katz & Jason Bradwell

Ross Katz and Jason Bradwell on why Nvidia paid $12.93B for Hugging Face, what owning AI demand gives it, and what enterprise teams should change.

41:11
Lisa Downey — DrugBank CEO: Why Your AI Model Gives You Half the Answer
Data in BiotechEp. 78

DrugBank CEO: Why Your AI Model Gives You Half the Answer

with Lisa Downey, DrugBank

DrugBank CEO Lisa Downey on why AI models give confident, incomplete drug-target answers, and four questions to ask before building a grounding layer.

52:12
Ross Katz & Jason Bradwell — The $1 Million Threshold for Self-Hosting Open-Weight AI Models
Eventual ConsistencyEp. 29

The $1 Million Threshold for Self-Hosting Open-Weight AI Models

with Ross Katz & Jason Bradwell

Ross Katz and Jason Bradwell on AT&T's open-weight bet, why routing produces most of the savings, and why self-hosting needs a $1M-a-year use case.

40:07
Erika Kvikstad — Genomic Data Bias, Fuzzy Phenotypes, and Drug Target Discovery
Data in BiotechEp. 77

Genomic Data Bias, Fuzzy Phenotypes, and Drug Target Discovery

with Erika Kvikstad, Independent

Erika Kvikstad on how reference genome bias and fuzzy heart failure phenotypes erode GWAS power, real-world data value, and cardiovascular target discovery.

70:08
Ross Katz & Jason Bradwell — How to Build a Data Team Ready for AI Agents
Eventual ConsistencyEp. 28

How to Build a Data Team Ready for AI Agents

with Ross Katz & Jason Bradwell

Ross Katz and Jason Bradwell on building a data team for AI agents: platform and distribution work for agents, warning signs, and build vs. buy vs. hire.

46:30
Adam Freund — From Single-Cell Data to Cell-Depleting Therapies
Data in BiotechEp. 76

From Single-Cell Data to Cell-Depleting Therapies

with Adam Freund, Arda Therapeutics

Arda CEO Adam Freund on finding pathogenic cells in single-cell data, the chi-squared trap, and why depletion can replace daily dosing.

54:12

Featured Guests From

Data leaders from 85+ companies have joined the conversation.

DrugBankIndependentArda TherapeuticsEstuaryGinkgo DatapointsWelocalizePsiTheraOxford Drug DesignUniversity of MichiganOverjetMerelogicFirezoneStandard Model BiomedicineSchrödingerReliant Life SciencesVistageAprecia PharmaceuticalsOpenBenchValo HealthDash BioHTD BiosystemsUniversity of Mississippi School of PharmacyVeloxity LabsSCIEXSerán BioScienceThermo Fisher ScientificSaturn CloudNebiusApherisConvoke+55 more

Frequently Asked
Questions

Who hosts the CorrDyn podcasts?
Data in Biotech is hosted by Ross Katz, CorrDyn's Principal and Data Science Lead. Eventual Consistency is co-hosted by Ross Katz and James Winegar, CorrDyn's co-founder, combining practitioner insight with business strategy perspective.
What topics do the podcasts cover?
Data in Biotech dives deep into the technical reality of how data methods drive value in biotech, pharma, and life sciences — covering everything from ML model development and manufacturing analytics to clinical data pipelines and computational biology. Episodes are relevant to both data leaders and data practitioners in the space. Eventual Consistency covers the broader data industry: data engineering trends, vendor landscape shifts, AI strategy, and the business side of building with data.
How often are new episodes released?
Each show releases new episodes every other week, and they alternate — so a new CorrDyn episode lands most weeks. Data in Biotech features guest interviews with data leaders, while Eventual Consistency is a co-hosted discussion format analyzing industry news and trends.
Where can I listen to the podcasts?
Both podcasts are available on Apple Podcasts, Spotify, YouTube, and most major podcast platforms. Full transcripts are available on the episode pages for readers who prefer text.
Are transcripts available for podcast episodes?
Yes. Full transcripts with speaker attribution are available on the episode pages for most episodes.

Get your free
proposal.

Tell us about your challenges. We will be honest about whether we can help.

  • No pitch decks. We start by listening.
  • Discovery calls are free.
  • We respond within one business day.

Or email us directly at [email protected]

No sales scripts. No commitments.